Pura Vida Investments is an investment fund managing more than $82.7 billion ran by Cara Bradfield. There are currently 25 companies in Mrs. Bradfield’s portfolio. The largest investments include Establishment Labs Inc and Glaukos, together worth $20.8 billion.
As of 7th August 2024, Pura Vida Investments’s top holding is 230,093 shares of Establishment Labs Inc currently worth over $10.5 billion and making up 12.6% of the portfolio value.
Relative to the number of outstanding shares of Establishment Labs Inc, Pura Vida Investments owns more than approximately 0.1% of the company.
In addition, the fund holds 87,000 shares of Glaukos worth $10.3 billion, whose value grew 28.1% in the past six months.
The third-largest holding is Intuitive Surgical Inc worth $8.41 billion and the next is Natera Inc worth $7.31 billion, with 67,500 shares owned.
Currently, Pura Vida Investments's portfolio is worth at least $82.7 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Pura Vida Investments office and employees reside in New York, New York. According to the last 13-F report filed with the SEC, Cara Bradfield serves as the Chief Financial Officer and Chief Compliance Officer at Pura Vida Investments.
In the most recent 13F filing, Pura Vida Investments revealed that it had opened a new position in
Icu Med Inc and bought 29,334 shares worth $3.48 billion.
The investment fund also strengthened its position in Glaukos by buying
8,000 additional shares.
This makes their stake in Glaukos total 87,000 shares worth $10.3 billion.
Glaukos soared 64.4% in the past year.
On the other hand, there are companies that Pura Vida Investments is getting rid of from its portfolio.
Pura Vida Investments closed its position in Exact Sciences on 14th August 2024.
It sold the previously owned 481,910 shares for $33.3 billion.
Cara Bradfield also disclosed a decreased stake in Establishment Labs Inc by 0.1%.
This leaves the value of the investment at $10.5 billion and 230,093 shares.
The two most similar investment funds to Pura Vida Investments are Covey Capital Advisors and Canaan Partners Xi. They manage $82.8 billion and $82.6 billion respectively.
Pura Vida Investments’s portfolio is diversified across 2 sectors.
Currently, their heaviest sector is Health Care — making up 83.2% of
the total portfolio value.
The fund focuses on investments in the United States as
60.0% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are small-cap stocks.
Stocks with a size of more than $100 million in market cap make up
8% of the total holdings value.
On the other hand, large-cap stocks make up only 4.0% of the portfolio.
The average market cap of the portfolio companies is close to $7.94 billion.
These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Exact Sciences Corp. |
Closed
481,910
|
$33,280,705,000 | |
| Establishment Labs Holdings Inc |
12.07%
230,093
|
$10,455,426,000 | 12.64% |
| Glaukos Corporation |
10.13%
87,000
|
$10,296,450,000 | 12.45% |
| Lyra Therapeutics, Inc. |
Closed
1,413,242
|
$8,790,365,000 | |
| Intuitive Surgical Inc |
21.41%
18,900
|
$8,407,665,000 | 10.17% |
| Natera Inc |
5.73%
67,500
|
$7,309,575,000 | 8.84% |
| Advisorshares Tr |
35.69%
787,000
|
$5,768,710,000 | 6.98% |
| Quanterix Corp |
8.87%
409,334
|
$5,407,302,000 | 6.54% |
| LivaNova PLC |
13.09%
78,350
|
$4,295,147,000 | 5.19% |
| Dexcom Inc |
Closed
30,000
|
$4,161,000,000 | |
| Icu Med Inc |
Opened
29,334
|
$3,483,413,000 | 4.21% |
| Castle Biosciences, Inc. |
Opened
153,386
|
$3,339,213,000 | 4.04% |
| Viking Therapeutics Inc |
Closed
39,868
|
$3,269,176,000 | |
| Pulmonx Corp |
9.89%
512,964
|
$3,252,192,000 | 3.93% |
| Inspire Med Sys Inc |
Closed
15,000
|
$3,221,850,000 | |
| Masimo Corp |
Opened
25,000
|
$3,148,500,000 | 3.81% |
| Shockwave Med Inc |
Closed
8,771
|
$2,856,101,000 | |
| Alphatec Holdings Inc |
37.82%
199,000
|
$2,079,550,000 | 2.51% |
| Bruker Corp |
Opened
32,500
|
$2,073,825,000 | 2.51% |
| Repligen Corp. |
Closed
11,225
|
$2,064,502,000 | |
| Guardant Health Inc |
Closed
100,000
|
$2,063,000,000 | |
| Cutera Inc |
8.07%
1,165,799
|
$1,760,356,000 | 2.13% |
| Tandem Diabetes Care Inc |
4.71%
40,500
|
$1,631,745,000 | 1.97% |
| Bioventus Inc |
Opened
280,000
|
$1,610,000,000 | 1.95% |
| Edwards Lifesciences Corp |
Closed
15,408
|
$1,472,388,000 | |
| Oncocyte Corporation |
5.46%
495,345
|
$1,461,268,000 | 1.77% |
| Staar Surgical Co. |
Opened
30,000
|
$1,428,300,000 | 1.73% |
| 10x Genomics, Inc. |
Closed
38,005
|
$1,426,328,000 | |
| Baxter International Inc. |
Closed
30,000
|
$1,282,200,000 | |
| Zimvie Inc |
4.23%
70,000
|
$1,277,500,000 | 1.54% |
| Treace Med Concepts Inc |
Closed
89,897
|
$1,173,156,000 | |
| InspireMD Inc |
No change
450,517
|
$1,124,175,000 | 1.36% |
| Metagenomi Inc |
41.33%
270,618
|
$1,038,964,000 | 1.26% |
| Myriad Genetics, Inc. |
Closed
44,725
|
$953,537,000 | |
| Elanco Animal Health Inc |
70.71%
56,603
|
$816,781,000 | 0.99% |
| AVITA Medical Inc |
Closed
35,000
|
$561,050,000 | |
| Twist Bioscience Corp |
Opened
10,000
|
$492,800,000 | 0.60% |
| Inari Med Inc |
Opened
10,000
|
$481,500,000 | 0.58% |
| Genedx Holdings Corp |
Opened
10,000
|
$261,400,000 | 0.32% |
| No transactions found | |||
| Showing first 500 out of 39 holdings | |||